News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Virostat Inc. Release: New Rhinovirus Monoclonal Antibodies



10/11/2013 10:19:32 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

October 11, 2013 -- Human Rhinoviruses are the most frequent cause of the common cold.

These small viruses are members of the Enterovirus genus and grow best at temperatures just below body temperature. Thus the nose and nasal passages are the ideal environment for them to localize. Person-to-person transmission occurs from aerosol transmission via sneezing and coughing as well as from contaminated surfaces.

There are 99 different Rhinovirus types based upon variation in the four outer capsid proteins (VP1-VP4). Reinfection with different types is common.

ViroStat has released 3 new monoclonal antibodies that have broad reactivity with several Rhinovirus types. These antibodies are reactive with the VP3 capsid protein and function in ELISA and IFA to detect these viruses.

Go to the ViroStat website, www.virostat-inc.com, to download the data sheet for these antibodies or contact them directly at 207-856-6620 for more information.

ViroStat, Inc. is a primary manufacturer of infectious disease antigens and antibodies, supplying researchers and manufacturers since 1985. Specialties include high affinity antibodies to Flu A, Flu B, RSV & Strep A for use in rapid lateral flow devices as well as antibodies to food-borne pathogens and toxins. Also, many specificities to HCV, HBV, CMV & EBV for use in anti-viral HTS assays

ViroStat, Inc.

PO Box 8522

Portland, ME 04104 USA

Phone: 207-856-6620

Fax: 207-856-6864

E-mail: info@virostat-inc.com

Web: www.virostat-inc.com

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES